SmeNSECLOSED
Modern Diagnostic IPO
₹85 – ₹85 · Issue Size ₹37 CrIPO Overview
Business Model
Competitive Advantages
- Experienced Promoter and Management Team:
- Our promoters bring over 50 years of combined experience in the healthcare industry, providing invaluable expertise and strategic
- We recognize that a motivated and skilled workforce is crucial for maintaining a competitive edge. Our dynamic team of key
IPO Timeline
Strengths & Weaknesses
Strengths
- Experienced Promoter and Management Team:
- Our promoters bring over 50 years of combined experience in the healthcare industry, providing invaluable expertise and strategic
- We recognize that a motivated and skilled workforce is crucial for maintaining a competitive edge. Our dynamic team of key
Management & Promoters
D
Devendra Singh YadavChairman cum Managing Director of the Company
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Modern Diagnostic IPO | — | — |
| ANCHOR INVESTOR PORTION ISSUE BID/ISSUE PERIOD*: TUESDAY DEC | 30.0x | — |
| Dated: December | 23.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| June 2025 | ₹0.17 Cr | ₹-0.21 Cr | ₹0.31 Cr | — |
| March 2025 | ₹0.18 Cr | ₹3 Cr | ₹0.03 Cr | — |
| 2024 | ₹0.01 Cr | ₹8.97 Cr | ₹0.01 Cr | — |
| 2023 | — | ₹5.79 Cr | — | — |
| November 2025 | — | ₹-5.73 Cr | — | — |
About
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology. Modern Diagnostic is involved in providing healthcare tests and services for diagnosis for individual patients, hospitals, healthcare providers, and corporate clients. The company offers many diagnostic services in radiology and pathology, such as ultrasound and c
| Exchange | NSE |
| Issue Type | sme |
| Face Value | ₹10 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.